Dr. Kuo is an Associate Professor of Neurology at Columbia University, and he is also a physician-scientist specializing in Movement Disorders. He is also the H. Houston Merritt endowed Associate Professor, a title held by Dr. Stanley Fahn for many years, and he succeeded the legacy. There is also an interesting story about this endowed position, as Dr. Houston Merritt is the funding father of modern neurology who discovered phenytoin as an anticonvulsant. Dr. Kuo has published extensively in the field of ataxia and tremor, including over 170 papers, 5 book chapters, and 1 book. He serves as the Chair for the Movement Disorders Section at the American Neurological Association and also a Scientific Advisor for the National Ataxia Foundation and International Essential Tremor Foundation. He is the Director of the Initiative for Columbia Ataxia and Tremor, an organization that brings together physicians, scientists, and engineers to advance therapies for cerebellar disorders. His lab uses multi-disciplinary approaches, ranging from the postmortem human brain, animal models, optogenetics, in vivo recording and human physiological recordings, to comprehensively
study the cerebellar circuit with the goal to finding ways to restore circuit dysfunction to reduce disabling movement disorders symptoms.
Cure Rare Disease, a non-profit organization (Tax ID number 82-2473513), is qualified as a tax-exempt organization under section 501(c)(3) of the IRS and has been designated as a “public charity” under section 170.